Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt No Debt
SPAN's Cash to Debt is ranked higher than
87% of the 377 Companies
in the Global Medical Devices industry.

( Industry Median: 6.28 vs. SPAN: No Debt )
SPAN' s 10-Year Cash to Debt Range
Min: 0.13   Max: No Debt
Current: No Debt

Equity to Asset 0.85
SPAN's Equity to Asset is ranked higher than
90% of the 358 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. SPAN: 0.85 )
SPAN' s 10-Year Equity to Asset Range
Min: 0.53   Max: 0.85
Current: 0.85

0.53
0.85
Interest Coverage 486.27
SPAN's Interest Coverage is ranked higher than
69% of the 222 Companies
in the Global Medical Devices industry.

( Industry Median: 205.72 vs. SPAN: 486.27 )
SPAN' s 10-Year Interest Coverage Range
Min: 69.61   Max: 9999.99
Current: 486.27

69.61
9999.99
F-Score: 6
Z-Score: 10.91
M-Score: -2.68
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 9.88
SPAN's Operating margin (%) is ranked higher than
79% of the 363 Companies
in the Global Medical Devices industry.

( Industry Median: 6.75 vs. SPAN: 9.88 )
SPAN' s 10-Year Operating margin (%) Range
Min: -0.43   Max: 13.42
Current: 9.88

-0.43
13.42
Net-margin (%) 6.86
SPAN's Net-margin (%) is ranked higher than
77% of the 363 Companies
in the Global Medical Devices industry.

( Industry Median: 5.06 vs. SPAN: 6.86 )
SPAN' s 10-Year Net-margin (%) Range
Min: 2.02   Max: 8.61
Current: 6.86

2.02
8.61
ROE (%) 16.83
SPAN's ROE (%) is ranked higher than
93% of the 363 Companies
in the Global Medical Devices industry.

( Industry Median: 5.79 vs. SPAN: 16.83 )
SPAN' s 10-Year ROE (%) Range
Min: 3.13   Max: 28.09
Current: 16.83

3.13
28.09
ROA (%) 13.93
SPAN's ROA (%) is ranked higher than
97% of the 377 Companies
in the Global Medical Devices industry.

( Industry Median: 3.38 vs. SPAN: 13.93 )
SPAN' s 10-Year ROA (%) Range
Min: 2.37   Max: 20.19
Current: 13.93

2.37
20.19
ROC (Joel Greenblatt) (%) 49.01
SPAN's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 376 Companies
in the Global Medical Devices industry.

( Industry Median: 12.75 vs. SPAN: 49.01 )
SPAN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1.4   Max: 61.7
Current: 49.01

-1.4
61.7
Revenue Growth (%) 10.20
SPAN's Revenue Growth (%) is ranked higher than
82% of the 278 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. SPAN: 10.20 )
SPAN' s 10-Year Revenue Growth (%) Range
Min: -4.5   Max: 16.8
Current: 10.2

-4.5
16.8
EBITDA Growth (%) 2.40
SPAN's EBITDA Growth (%) is ranked higher than
78% of the 249 Companies
in the Global Medical Devices industry.

( Industry Median: -3.70 vs. SPAN: 2.40 )
SPAN' s 10-Year EBITDA Growth (%) Range
Min: -15   Max: 46.6
Current: 2.4

-15
46.6
EPS Growth (%) 2.10
SPAN's EPS Growth (%) is ranked higher than
78% of the 233 Companies
in the Global Medical Devices industry.

( Industry Median: -2.80 vs. SPAN: 2.10 )
SPAN' s 10-Year EPS Growth (%) Range
Min: -17.8   Max: 133.9
Current: 2.1

-17.8
133.9
» SPAN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

SPAN Guru Trades in Q1 2013

Jim Simons 38,400 sh (+8.47%)
» More
Q2 2013

SPAN Guru Trades in Q2 2013

Jim Simons 39,400 sh (+2.6%)
» More
Q3 2013

SPAN Guru Trades in Q3 2013

Jim Simons 43,600 sh (+10.66%)
» More
Q4 2013

SPAN Guru Trades in Q4 2013

Jim Simons 48,500 sh (+11.24%)
» More
» Details

Insider Trades

Latest Guru Trades with SPAN



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 14.70
SPAN's P/E(ttm) is ranked higher than
91% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 26.70 vs. SPAN: 14.70 )
SPAN' s 10-Year P/E(ttm) Range
Min: 4.96   Max: 24.6
Current: 14.7

4.96
24.6
P/B 2.10
SPAN's P/B is ranked higher than
70% of the 355 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. SPAN: 2.10 )
SPAN' s 10-Year P/B Range
Min: 1.12   Max: 5.55
Current: 2.1

1.12
5.55
P/S 0.96
SPAN's P/S is ranked higher than
83% of the 378 Companies
in the Global Medical Devices industry.

( Industry Median: 2.80 vs. SPAN: 0.96 )
SPAN' s 10-Year P/S Range
Min: 0.4   Max: 1.42
Current: 0.96

0.4
1.42
PFCF 13.85
SPAN's PFCF is ranked higher than
89% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 27.48 vs. SPAN: 13.85 )
SPAN' s 10-Year PFCF Range
Min: 5.24   Max: 218.83
Current: 13.85

5.24
218.83
EV-to-EBIT 9.29
SPAN's EV-to-EBIT is ranked higher than
91% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 20.80 vs. SPAN: 9.29 )
SPAN' s 10-Year EV-to-EBIT Range
Min: 3.1   Max: 19.6
Current: 9.29

3.1
19.6
PEG 8.17
SPAN's PEG is ranked lower than
55% of the 119 Companies
in the Global Medical Devices industry.

( Industry Median: 2.53 vs. SPAN: 8.17 )
SPAN' s 10-Year PEG Range
Min: 0.14   Max: 52.96
Current: 8.17

0.14
52.96
Shiller P/E 12.75
SPAN's Shiller P/E is ranked higher than
98% of the 141 Companies
in the Global Medical Devices industry.

( Industry Median: 26.95 vs. SPAN: 12.75 )
SPAN' s 10-Year Shiller P/E Range
Min: 7.27   Max: 31.28
Current: 12.75

7.27
31.28

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.50
SPAN's Dividend Yield is ranked higher than
83% of the 166 Companies
in the Global Medical Devices industry.

( Industry Median: 1.29 vs. SPAN: 2.50 )
SPAN' s 10-Year Dividend Yield Range
Min: 0.89   Max: 4.38
Current: 2.5

0.89
4.38
Dividend Payout 0.65
SPAN's Dividend Payout is ranked higher than
62% of the 141 Companies
in the Global Medical Devices industry.

( Industry Median: 0.35 vs. SPAN: 0.65 )
SPAN' s 10-Year Dividend Payout Range
Min: 0.13   Max: 2.5
Current: 0.65

0.13
2.5
Dividend growth (3y) 8.80
SPAN's Dividend growth (3y) is ranked higher than
82% of the 67 Companies
in the Global Medical Devices industry.

( Industry Median: 8.20 vs. SPAN: 8.80 )
SPAN' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 27.4
Current: 8.8

0
27.4
Yield on cost (5-Year) 3.88
SPAN's Yield on cost (5-Year) is ranked higher than
89% of the 169 Companies
in the Global Medical Devices industry.

( Industry Median: 1.35 vs. SPAN: 3.88 )
SPAN' s 10-Year Yield on cost (5-Year) Range
Min: 1.38   Max: 6.8
Current: 3.88

1.38
6.8
Share Buyback Rate -1.80
SPAN's Share Buyback Rate is ranked higher than
74% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: -1.30 vs. SPAN: -1.80 )
SPAN' s 10-Year Share Buyback Rate Range
Min: 7.9   Max: -2.6
Current: -1.8

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 7.46
SPAN's Price/Net Current Asset Value is ranked higher than
59% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: 8.80 vs. SPAN: 7.46 )
SPAN' s 10-Year Price/Net Current Asset Value Range
Min: 1.72   Max: 116.67
Current: 7.46

1.72
116.67
Price/Tangible Book 2.81
SPAN's Price/Tangible Book is ranked higher than
70% of the 326 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. SPAN: 2.81 )
SPAN' s 10-Year Price/Tangible Book Range
Min: 0.68   Max: 5.95
Current: 2.81

0.68
5.95
Price/DCF (Projected) 0.89
SPAN's Price/DCF (Projected) is ranked higher than
89% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SPAN: 0.89 )
SPAN' s 10-Year Price/DCF (Projected) Range
Min: 0.35   Max: 2.65
Current: 0.89

0.35
2.65
Price/Median PS Value 1.35
SPAN's Price/Median PS Value is ranked lower than
53% of the 334 Companies
in the Global Medical Devices industry.

( Industry Median: 1.10 vs. SPAN: 1.35 )
SPAN' s 10-Year Price/Median PS Value Range
Min: 0.49   Max: 1.76
Current: 1.35

0.49
1.76
Price/Graham Number 1.34
SPAN's Price/Graham Number is ranked higher than
81% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. SPAN: 1.34 )
SPAN' s 10-Year Price/Graham Number Range
Min: 0.56   Max: 1.85
Current: 1.34

0.56
1.85
Earnings Yield (Greenblatt) 10.80
SPAN's Earnings Yield (Greenblatt) is ranked higher than
92% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: 4.50 vs. SPAN: 10.80 )
SPAN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5.1   Max: 32
Current: 10.8

5.1
32
Forward Rate of Return (Yacktman) 7.76
SPAN's Forward Rate of Return (Yacktman) is ranked higher than
85% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. SPAN: 7.76 )
SPAN' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 3.6   Max: 41.4
Current: 7.76

3.6
41.4

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Span-America Medical Systems, Inc., is incorporated under the laws of the state of South Carolina on September 21, 1970. The Company manufactures and distributes a variety of therapeutic support surfaces and related products utilizing polyurethane and other foam products for the medical, consumer and industrial markets. Its operations are divided into two main business units or segments: medical and custom products. The Company's main medical products consist of polyurethane foam mattress overlays, therapeutic support surfaces (which consist of non-powered and powered therapeutic support surfaces) and patient positioners as well as Selan skin care, seating and fall protection products. The Company's custom products segment includes two product lines: consumer bedding products and various engineered industrial products. The Company's consumer product line consists mainly of convoluted and contour-cut mattress overlays and specially designed pillows for the consumer bedding market. The consumer products are marketed to retailers through Louisville Bedding Company, a manufacturer and distributor of bedding products in North America. It sells these products mainly in North America to customers in the major segments of the health care market, including acute care hospitals, long-term care facilities and home health care providers. The Company's manufacturing operations are subject to various government regulations pertaining to the discharge of materials into the environment.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide